 BEIJING--BUSINESS WIRE--Sinovac Biotech Ltd. Sinovac or the Company NASDAQ: SVA, a leading provider of biopharmaceutical products in China, today announced that Sinovac Life Sciences Co., Ltd. Sinovac LS formerly known as Sinovac Research and Development Co., Ltd., a subsidiary of Sinovac, has secured approximately US500 million in funding for further development, capacity expansion and manufacturing of the CoronaVac, its COVID-19 vaccine candidate, as well as conduct other dev 